Renal cancer
Conditions
Interventions
None listed
Sponsors
Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Renal clear cell carcinoma diagnosed by pathology; 2. Patients considered as advanced/metastatic clear cell renal carcinoma by imaging examination including PET-CT, CT or MRI: T4N0-1M0/T1-4N0-1M1; 3. Surgical tumor reduction treatment was performed; 4. ECOG score <= 2; 5. Renal cell carcinoma tissues can be obtained for immunohistochemical staining of VHL protein and CAIX protein.
Exclusion criteria
Exclusion criteria: 1. Patients with life expectancy is less than 1 year at the time of diagnosis of renal cell carcinoma; 2. Patients with other neoplastic diseases; 3. Renal cell carcinoma with other pathological types other than renal clear cell carcinoma; 4. Patients with severe liver function impairment in the diagnosis of renal cell carcinoma (Child-Pugh grade C); 5. Patients with severe renal function injury requiring long-term dialysis treatment when diagnosing renal cancer; 6. Patients with severe bone marrow suppression and severe neutropenia when diagnosing renal cell carcinoma.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Progress-free survival; | — |
Countries
China
Contacts
Public ContactHeng Li
Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology
Outcome results
None listed